Abstract
Sildenafil is used as off-label medication in pulmonary hypertension (PH) secondary to valvular heart disease (VHD). To date, limited investigations and guidelines are available to recommend the usefulness of sildenafil in this group of patients. Previously, published systematic review only reported the efficacy of sildenafil for PH with VHD in preoperative conditions.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
